Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP800848.RAtoYnQRclJyfTO85-gII0rXEcc6XKJDOzS-u3Z4kvzXQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP800848.RAtoYnQRclJyfTO85-gII0rXEcc6XKJDOzS-u3Z4kvzXQ130_assertion type Assertion NP800848.RAtoYnQRclJyfTO85-gII0rXEcc6XKJDOzS-u3Z4kvzXQ130_head.
- NP800848.RAtoYnQRclJyfTO85-gII0rXEcc6XKJDOzS-u3Z4kvzXQ130_assertion description "[p53 is usually inactivated by point mutations during tumorigenesis, whereas the expression levels and p63 and p73 are modulated to give tumor cells a selective advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800848.RAtoYnQRclJyfTO85-gII0rXEcc6XKJDOzS-u3Z4kvzXQ130_provenance.
- NP800848.RAtoYnQRclJyfTO85-gII0rXEcc6XKJDOzS-u3Z4kvzXQ130_assertion evidence source_evidence_literature NP800848.RAtoYnQRclJyfTO85-gII0rXEcc6XKJDOzS-u3Z4kvzXQ130_provenance.
- NP800848.RAtoYnQRclJyfTO85-gII0rXEcc6XKJDOzS-u3Z4kvzXQ130_assertion SIO_000772 20298673 NP800848.RAtoYnQRclJyfTO85-gII0rXEcc6XKJDOzS-u3Z4kvzXQ130_provenance.
- NP800848.RAtoYnQRclJyfTO85-gII0rXEcc6XKJDOzS-u3Z4kvzXQ130_assertion wasDerivedFrom befree-2016 NP800848.RAtoYnQRclJyfTO85-gII0rXEcc6XKJDOzS-u3Z4kvzXQ130_provenance.
- NP800848.RAtoYnQRclJyfTO85-gII0rXEcc6XKJDOzS-u3Z4kvzXQ130_assertion wasGeneratedBy ECO_0000203 NP800848.RAtoYnQRclJyfTO85-gII0rXEcc6XKJDOzS-u3Z4kvzXQ130_provenance.